Chevy Chase Trust
NWBO

Chevy Chase Trust’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Chevy Chase Trust’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-37,854
Closed -$21K – 687
2016
Q3 		$21K Hold
37,854
– – ﹤0.01% 650
2016
Q2 		$22K Hold
37,854
– – ﹤0.01% 647
2016
Q1 		$55K Buy
37,854
+989
+3% +$1.95K ﹤0.01% 649
2015
Q4 		$118K Hold
36,865
– – ﹤0.01% 650
2015
Q3 		$230K Hold
36,865
– – ﹤0.01% 628
2015
Q2 		$366K Hold
36,865
– – ﹤0.01% 603
2015
Q1 		$272K Hold
36,865
– – ﹤0.01% 625
2014
Q4 		$197K Hold
36,865
– – ﹤0.01% 673
2014
Q3 		$185K Hold
36,865
– – ﹤0.01% 678
2014
Q2 		$247K Hold
36,865
– – ﹤0.01% 649
2014
Q1 		$267K Hold
36,865
– – ﹤0.01% 632
2013
Q4 		$139K Buy
+36,865
New +$143K ﹤0.01% 639

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Chevy Chase Trust's NWBO Position: Q4 2016 in Review

Chevy Chase Trust sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 37,854 shares — an estimated $21K sold.

Chevy Chase Trust first reported a position in NWBO in Q4 2013 and held it in 12 quarters. The position peaked at $366K in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Chevy Chase Trust reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Chevy Chase Trust sold 37,854 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $21K.
  • Chevy Chase Trust first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2013 and held it in 12 quarters.
  • Chevy Chase Trust's Northwest Biotherapeutics, Inc. Common stock position peaked at $366K in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Chevy Chase Trust's 13F filing for Q4 2016, filed 9 Jan 2017.